News
Discover how tirzepatide aids weight loss and insulin reduction in Type 1 diabetes with no increase in hypoglycaemia.
GoodRx reports tips for safely switching between GLP-1 medications due to side effects, insurance changes, or treatment goals ...
Altimmune, Inc.'s pemvidutide shows promise in weight loss and MASH but faces challenges. Click for my updated look at ALT ...
GLP-1RAs were associated with a reduced risk for neurodegenerative and cerebrovascular diseases in type 2 diabetes and obesity.
A relatively old drug -- metformin -- may hold the key to preventing life-threatening illness and bolstering human longevity, ...
New recommendations suggest holding back on SGLT2 inhibitors and GLP-1s among those at a lower risk for cardiovascular or ...
Non-arteritic anterior ischaemic optic neuropathy, or NAION, is a rare but devastating eye condition that occurs when blood ...
SGLT-2 inhibitor and GLP-1 receptor agonist drugs should be used in all or almost all adults with type 2 diabetes at higher ...
By Brooke Hudspeth, Pharm.D. University of Kentucky You’ve likely heard about glucagon-like peptide-1 agonists – usually referred to as GLP-1 medications, and more wildly recognized through ...
SGLT-2 inhibitor and GLP-1 receptor agonist drugs should be used in all or almost all adults with type 2 diabetes at higher ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results